Physician profile
Leon Scrimmager
NPI 1215020474
$2,459.70
in general payments reported to CMS, 2019-2025
23 companies · $26.59 in 2025
The $26.59 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,201 · 2020: $592 · 2021: $442 · 2022: $198 · 2025: $26.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $450.75 | 2019-2022 | |
| Gilead Sciences, INC. | $368.63 | 2019 | |
| Glaxosmithkline, LLC. | $219.19 | 2019-2020 | |
| Amarin Pharma, INC. | $213.64 | 2019-2022 | |
| Abbvie INC. | $186.28 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $183.32 | 2019-2020 | |
| Boston Scientific Corporation | $116.49 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $102.93 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $90.80 | 2019-2020 | |
| Novo Nordisk INC | $78.32 | 2019-2021 | |
| Bausch Health US, LLC | $62.97 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $59.00 | 2019-2021 | |
| Assertio Therapeutics, INC. | $45.77 | 2020 | |
| Medicomp INC | $43.31 | 2022-2025 | Telepatch Cardiac Monitor |
| Daiichi Sankyo INC. | $38.40 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.19 | 2019-2022 | |
| Biogen, INC. | $35.05 | 2021-2022 | |
| Qol Medical, LLC | $32.00 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $23.56 | 2020 | |
| Neurocrine Biosciences, INC. | $22.03 | 2021 | |
| Intercept Pharmaceuticals, INC. | $18.17 | 2021 | |
| Allergan, INC. | $17.34 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $13.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Scrimmager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.